Gene Query: KXD1

Dataset Description Geneva Score
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 39.07
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 35.97
Genome wide expression change by RNF168 knocking down in MCF-7 cells 33.82
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 27.89
Active translatome profiling with RiboLace in MCF7 cells 27.45
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 26.37
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 22.18
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 19.13
HEXIM1 is induced by DHODH inhibition to suppress melanoma 18.92
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 18.92
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 16.16
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 15.44
An integrative analysis of non-coding regulatory DNA variations associated with autism 14.7
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 13.62
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.02
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 12.86
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.45
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 12.22
Transcriptome of diurnal human blood neutrophils 11.68
Argonaute proteins couple chromatin silencing to alternative splicing 11.63
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 11.63
Metastasis in triple-negative breast cancer 11.5
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 11.5
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 11.45
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 11.28
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.28
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.28
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.2
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.2
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 11.06
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 11.06
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 10.69
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.38
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  10.34
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.32
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 10.12
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.07
RNA sequencing of primary human platelets and in vitro cell lines 10.04
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.02
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 9.82
N6-methyladenine DNA Modification in Glioblastoma 9.82
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.72
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 9.69
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.57
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.49
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.49
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.46
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.42
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.42
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 9.39
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 9.39
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.16
Transcriptomic analyssis following EHMT1/2 inhibition 9.02
METTL3 promotes translation in human cancer cells 9.01
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 8.95
Global transcriptome analysis of HAP1 cells 8.95
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 8.68
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.63
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 8.54
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.38
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 8.37
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 8.32
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.26
Effect of PRDM11 depletion in U2932 cells 8.2
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.16
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.11
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.1
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.1
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.09
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 8.0
Impact of dieldrin on transcription in Jurkat T cells 7.94
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.93
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.93
Global analysis of enhancer targets: Mosaic-seq 7.92
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.91
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 7.79
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.71
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.71
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 7.68
SLAM-seq for K562 endogenous mRNA decay 7.67
scRNASeq analysis of cycling cardiomyocytes 7.63
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.57
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.55
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.49
Patient-derived luminal breast cancer xenografts with progestins 7.49
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.48
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 7.43
Human Treg NaCl stimulation 7.42
Transcriptional effect of ETV1 knockdown in melanoma cells 7.35
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.34
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.32
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 7.3
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.27
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 7.25
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.14
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.13
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.13
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 7.12
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 7.01
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.9
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.89
The regulartory role of ZCCHC24 in splicing machinery 6.89
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.86
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.83
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.82
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.73
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 6.72
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 6.72
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 6.62
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.53
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.38
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.32
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 6.23
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.14
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 6.12
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.08
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 6.08
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.07
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 6.07
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.07
Ectoderm specification of H1 human embryonic stem cells 6.04
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.0
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.95
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.94
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.93
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.93
3’ Uridylation Expands miRNA Target Repertoire 5.92
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 5.9
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.87
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 5.86
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 5.86
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 5.85
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 5.85
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 5.82
RNA-seq of naive and primed ES cells (NHSM) 5.77
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 5.69
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.68
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 5.63
Retinoic acid suppresses MYB in adenoid cystic carcinoma 5.63
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.59
CROP-Seq in Primary Human T Cells 5.59
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.56
Trans-differentiation of human adult peripheral blood T cells into neurons 5.56
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 5.56
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.56
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.55
RNA-seq of IL-4 stimulated human keratinocytes 5.54
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.53
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 5.51
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 5.5
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.46
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.46
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 5.43
High-throughput sequencing of pluripotent cells 5.43
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.42
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 5.42
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.41
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 5.41
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.39
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.39
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 5.38
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.36
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 5.35
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 5.35
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.32
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 5.31
Neurofibroma 5.31
miR941 overexpression experiment 5.31
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 5.3
Differential gene expression of human melanoma cells [RNA-seq] 5.24
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 5.24
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.23
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.23
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.22
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.21
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.2
PRDM1 inhibits proliferation of human colon cancer organoids 5.19
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.16
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.13
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.13
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 5.11
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 5.11
Functional role of CPPED1 in trophoblasts. 5.09
Aortic Valve Tissue: Stenosis vs. Sclerosis 5.09
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.04
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 5.03
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 5.03
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 5.02
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 5.0
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 5.0
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.0
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.98
mRNA expression in human DAOY cells 4.98
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.95
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.95
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.94
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 4.94
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.91
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.9
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.9
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.9
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.89
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.89
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.89
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.89
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.89
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.84
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.84
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.83
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 4.8
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.79
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.75
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.75
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.74
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.74
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.73
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 4.73
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 4.73
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.71
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.71
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.7
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.7
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.69
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.64
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.59
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 4.52
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.49
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 4.49
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 4.48
mRNA expression profile of Lymphocytes 4.44
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.44
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.42
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.42
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.42
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 4.42
Illumina Total RNA-seq in HeLa 4.4
The comparison of high-throughput single-cell RNA-seq methods 4.32
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.27
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 4.23
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.22
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.2
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 4.18
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.18
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.18
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.17
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.17
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.12
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.1
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.1
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.1
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.1
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.08
X-Ray induced DNA-Hydroxymethylation changes 4.05
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.03
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.01
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.0
PTHrP overexpression in MCF7 cells 4.0
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.93
Hepatocyte maturation 3.91
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.88
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.88
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.8
Energy Metabolism during Anchorage-Independence 3.78
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.78
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.74
RNA-Seq from human ILC transitional populations 3.74
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.7
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.63
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.63
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.62
Hepatitis C virus functionally sequesters miR-122 3.6
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.6
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.6
RNA seq comparison between scrambled and shGRP78 cells 3.59
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.57
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.48
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.43
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.43
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 3.39
K562 polyA RNA-Seq 3.33
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 3.33
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.3
m6A-dependent regulation of messenger RNA stability 3.28
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.25
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.21
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 3.19
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.15
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.14
Landscape and variation of RNA secondary structure across the human transcriptome 3.14
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.13
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.13
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.08
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.05
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.01
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.01
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.96
Positively selected enhancer elements endow tumor cells with metastatic competence 2.88
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 2.87
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 2.87
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.87
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.85
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.84
A single-cell transcriptome atlas of the human pancreas 2.83
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.82
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.77
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.76
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.75
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.75
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.69
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.69
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.66
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.64
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.63
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.62
Ribosome profiling upon inhibition of eIF4A 2.61
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 2.59
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.58
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.56
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.53
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 2.52
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.52
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.52
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.5
Mapping interactions for the TNIP2 hub protein 2.42
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.41
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.41
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.41
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.38
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.33
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.32
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.3
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.25
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.18
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.16
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.13
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.12
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.12
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.07
mRNA recovered upon RNF219 IP. [RNA-IP] 2.07
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 2.07
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.04
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.0
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.98
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.94
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.92
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.91
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.91
NAPRT activation of macrophages 1.89
miR-93 Targets in Human Endothelial Cells 1.89
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.87
Gene expression profile in breast cancer cells 1.86
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.86
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.85
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.83
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 1.8
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 1.8
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.78
RNA editing in nascent RNA affects pre-mRNA splicing 1.77
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.76
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.72
RNA-sequencing of healthy human skeletal myocytes 1.72
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.72
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.69
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.68
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.68
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.68
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.61
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.61
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.57
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.51
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.5
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.5
Gene expressions of H9s in different culture systems 1.5
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.48
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.48
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.47
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.47
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.46
Functional significance of the HIV-1 Tat signature amino acid residues 1.43
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 1.41
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.4
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.4
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 1.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.38
Transcriptome analysis of kidney organoids 1.37
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.33
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.32
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.3
Induced DNA demethylation, genome instability and transcription 1.29
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.29
MicroRNA-125a-5p overexpression in human macrophages 1.29
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.28
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.28
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.28
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.26
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.26
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 1.26
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.23
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.23
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.22
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.21
The bromodomain protein BRD4 regulates splicing during heat shock 1.2
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.19
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.18
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.18
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.16
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.15
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.09
SRSF1 role in cellular gene expression and splicing 1.09
Ribosomal protein RPL26 is the principal target of UFMylation 1.08
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.08
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.07
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.03
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 1.02
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 1.02
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.02
Human Treg IL-12 stimulation 1.0
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.98
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.96
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.96
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.94
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.94
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.92
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.91
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.86
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.86
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.86
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.81
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 0.81
RNA-Seq of PRMT1 overexpression ECA109 cells 0.8
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.77
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.75
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.75
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.73
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.71
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.71
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.7
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.67
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 0.65
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.65
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.64
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.64
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.64
Downregulation of LATS kinases alters p53 to promote cell migration 0.64
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.59
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.59
Global transcriptome analysis of WT versus HEB-/- hESCs 0.58
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.58
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.57
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.56
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.52
Comparative Analysis of Cas9 Activators Across Multiple Species 0.47
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.47
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.47
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.45
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.45
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.43
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.42
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.38
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.37
Human Treg IFNg/IL-10 subpopulations 0.37
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.36
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.33
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.32
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.32
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.29
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.29
Effect of ILF3 on translation during homeostasis and the antiviral response 0.23
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.22
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.2
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.19
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.18
The DPYSL2 gene connects mTOR and schizophrenia 0.17
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.17
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.14
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.12
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.12
MHC Transcriptomic landscape at haplotype-specific resolution 0.12
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.12
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.12
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.1
Transcriptomic analysis of LSD1 0.06
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.04
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.03
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.02
Metabolism as an early predictor of DPSCs aging 0.02
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.02
The role of m6A/m-RNA methylation in stress response regulation 0.01
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.01
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.0
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation